title: In vitro profiling of pramiconazole and in vivo evaluation in Microsporum canis dermatitis and Candida albicans vaginitis laboratory models.
abstract: The triazole antifungal pramiconazole (Stiefel, a GSK company) was compared with itraconazole, miconazole, and terbinafine in vitro and in vivo. Potent in vitro activities against Candida spp. (50% inhibitory concentration [IC₅₀], 0.04 to 1.83 μM) and Microsporum and Trichophyton spp. (IC₅₀, 0.15 to 1.34 μM) were obtained but not, however, against other filamentous molds and zygomycetes. In the M. canis guinea pig model and C. albicans vulvovaginitis rat model, pramiconazole was superior to the reference compounds after oral and topical administration.
authors.affiliation: Laboratory of Microbiology, Parasitology and Hygiene, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Antwerp University, Groenenborgerlaan 171, Antwerp, Belgium.
authors.forename: Kelly
authors.initials: K
authors.lastname: de Wit
authors.forename: Caroline
authors.initials: C
authors.lastname: Paulussen
authors.forename: An
authors.initials: A
authors.lastname: Matheeussen
authors.forename: Koen
authors.initials: K
authors.lastname: van Rossem
authors.forename: Paul
authors.initials: P
authors.lastname: Cos
authors.forename: Louis
authors.initials: L
authors.lastname: Maes
mesh_terms: D000287:Administration, Topical; D000818:Animals; D000935:Antifungal Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D002176:Candida albicans / Q000472:pathogenicity*; D003872:Dermatitis / Q000382:microbiology*; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007093:Imidazoles / Q000493:pharmacokinetics / Q000627:therapeutic use*; D020128:Inhibitory Concentration 50; D017964:Itraconazole / Q000493:pharmacokinetics / Q000627:therapeutic use; D008864:Microsporum / Q000472:pathogenicity*; D009281:Naphthalenes / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077291:Terbinafine; D014230:Triazoles / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014627:Vaginitis / Q000382:microbiology*
chemical_list: D000935:Antifungal Agents; D007093:Imidazoles; D009281:Naphthalenes; D014230:Triazoles; D017964:Itraconazole; C482452:pramiconazole; D000077291:Terbinafine
references.citation: Eur J Clin Microbiol Infect Dis. 2006 Apr;25(4):215-29
references.pmid: 16568297
references.citation: J Ethnopharmacol. 2006 Jul 19;106(3):290-302
references.pmid: 16698208
references.citation: Acta Derm Venereol. 2008;88(5):462-6
references.pmid: 18779883
references.citation: Int J Hyg Environ Health. 2001 Dec;204(4):239-43
references.pmid: 11833296
references.citation: Acta Derm Venereol. 2007;87(1):22-6
references.pmid: 17225011
references.citation: J Med Chem. 2005 Mar 24;48(6):2184-93
references.pmid: 15771461
references.citation: Clin Dermatol. 2010 Mar 4;28(2):197-201
references.pmid: 20347663
references.citation: J Clin Microbiol. 1995 Apr;33(4):915-7
references.pmid: 7790460
references.citation: Antimicrob Agents Chemother. 2004 Jan;48(1):216-23
references.pmid: 14693542
references.citation: Mycopathologia. 2008 Nov-Dec;166(5-6):353-67
references.pmid: 18478357
references.citation: Acta Derm Venereol. 2006;86(4):312-5
references.pmid: 16874415
references.citation: Antimicrob Agents Chemother. 1987 Oct;31(10):1558-61
references.pmid: 3435103
references.citation: Am Fam Physician. 2003 Jan 1;67(1):101-8
references.pmid: 12537173
references.citation: Br J Dermatol. 2007 Jun;156(6):1385-8
references.pmid: 17535237
references.citation: IDrugs. 2008 Sep;11(9):661-70
references.pmid: 18763217
references.citation: Antimicrob Agents Chemother. 2004 Feb;48(2):388-91
references.pmid: 14742185
references.citation: Drugs. 2004;64(18):1997-2020
references.pmid: 15341494
references.citation: Lancet. 2007 Jun 9;369(9577):1961-71
references.pmid: 17560449
references.citation: Br J Dermatol. 2008 Apr;158(4):854-6
references.pmid: 18241269
references.citation: Dermatology. 2007;214(2):162-9
references.pmid: 17341867
references.citation: Curr Drug Targets. 2005 Dec;6(8):849-62
references.pmid: 16375669